Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 11 June 2012 | By Ansis Helmanis,
The Board of Anvisa, the national regulatory authority of Brazil, is scheduled to review new regulations governing the format of "non-print" instructions for use of health products and the criteria for a therapeutic indication at its next public meeting.
The Board will also receive a report by the Chief Executive Officer of Anvisa, Dirceu Barbano, on the international meeting of national regulators held in Geneva on 18 May that was organized by the agency on the topic of improving international regulatory cooperation.
Barbano will also report on the bilateral agreement signed in Germany between Anvisa and the Institute of Toxicological Evaluation of Germany.
The meeting will be held 14 June 2012.
Read more:
Anvisa - Anvisa announces agenda for the next public meeting of the Board
More Breaking News from RegLink
Tags: Therapeutic Indications, Barbano, Board, Public Meeting, brazil
Regulatory Focus newsletters
All the biggest regulatory news and happenings.